New Releases from NCBI BookshelfTalazoparib with enzalutamide for untreated hormone-relapsed metastatic prostate cancer.Talazoparib with enzalutamide for untreated hormone-relapsed metastatic prostate cancer.
Post Content
This study employed an interdisciplinary approach to assess the impact of agricultural production modifications and dietary changes on ammonia emissions,
This systematic review (SR) aimed to evaluate the comparative effectiveness and harms of medical therapies for non-metastatic, locally advanced gastric
Post Content
There are increasing numbers of cancer survivors who have finished their primary treatment, but whose quality of life remains consistently
Behavioural weight management interventions are the main treatment for obesity in the United Kingdom; however, there are limitations in the